Early 2009, eight human infection cases of H5N1 highly pathogenic avian influenza (HPAI) virus, with 5 death cases, were reported in China. This again made the world alert on a possible pandemic worldwide, probably caused by avian-origin avian influenza virus. Again H5N1 is in the spotlight of the world, not only for the scientists but also for the ordinary people.

Preliminary research from the Department of Respiratory Disease Research at the Naval Health Research Center (NHRC) suggests that a rapid antigen assay test developed by Arbor Vita Corporation (AVC) shows promise as a useful diagnostic for the detection of the avian influenza virus in humans.

The international science community is not doing enough to track the many avian influenza viruses that might cause the next pandemic, a UC Davis researcher says in today's issue of the journal Nature.

Researchers from the National Institutes of Health and University of Maryland report that a new vaccine that protects monkeys against the avian influenza virus is now a candidate for clinical trial in humans. They report their findings in the November 2007 issue of the Journal of Virology.

Veterinarians who work with birds are at increased risk for infection with avian influenza virus and should be among those with priority access to pandemic influenza vaccines and antivirals, according to a study conducted by researchers in the University of Iowa College of Public Health.